Multiple myeloma oncogene 1, technical only
Use
Multiple myeloma 1 (MUM1) is normally expressed in plasma cells, activated B cells, and activated T cells. Translocation to the Ig heavy chain locus is commonly observed in multiple myeloma causing consistent MUM1 expression. MUM1 is also found in a range of lymphoid neoplasms, including a proportion of diffuse B cell lymphomas, Reed Sternberg cells in Hodgkin's disease, and neoplastic T cells. The test is intended for detecting MUM1 expression in these conditions, aiding in the diagnosis and research of lymphoid neoplasms.
Special Instructions
Not provided.
Limitations
The performance of this assay has not been established in tissues other than those collected according to the specified procedures. Specimens must be fixed in 10% neutral buffered formalin (NBF) or B plus; all other fixatives will be rejected. The test does not include pathologist interpretation, which must be arranged separately.
Methodology
Immunoassay (IHC)
Biomarkers
Multiple myeloma oncogene 1
Protein
Result Turnaround Time
2 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (Fixed (Non-FFPE))
Volume
Not provided
Minimum Volume
Not provided
Container
Fresh Tissues
Collection Instructions
Fixative should be at a 20:1 fixative to tissue ratio, 10% neutral buffered formalin (NBF) for 6-72 hours (48-72 hours PREFERRED)
Storage Instructions
15°C to 25°C
Causes for Rejection
Specimens must be fixed in 10% NBF or B plus. All other fixatives will be rejected.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | ≤ 72 Hours |